Articles tagged as

Food and Drug Administration

  1. The Biggest Risks of Investing in Johnson & Johnson Stock (JNJ)

  2. The Biggest Risks of Investing in Celgene Stock (CELG)

  3. The Biggest Risks of Investing in Altria Stock (MO)

  4. The Top 5 Health Care Penny Stocks for 2016 (CRIS, GERN)

  5. The Top 5 Mid-Cap Biotechnology Stocks for 2016 (ALNY, ICPT)

  6. SBIO: ALPS Medical Breakthroughs ETF

  7. PPH: Market Vectors Pharmaceutical ETF

  8. The Biggest Risks of Investing in Pfizer Stock (PFE)

  9. How Will e-cigarettes Affect Big Tobacco? (RAI, PM)

  10. Celgene Vs. Gilead: Vetting for the Best Biopharma

  11. 10 Developments By Gilead Sciences That Could Boost Profits (GILD)

  12. How to Profit from the Generic Drug Trend

  13. How Does Biogen Make its Money?

  14. How NDAs Work and Why They're Important

  15. Could Amgen's Next Drug Be Worth $100 Billion?

  16. 3 Things That Could Hold Intuitive Surgical Back

  17. Did Orexigen Make A Big Mistake?

  18. Are These Biogen Idec's Next Blockbusters?

  19. Why Does Wall Street Hate MannKind?

  20. What’s The Drug That Will Finally Fight Obesity?

  21. Is Ariad On Track To Lose More Shares?

  22. What Is Amgen’s New Target?

  23. Will MannKind Finally Reach A Solid Ground?

  24. What Are The Real Economic Costs Of Obesity?

  25. Gilead Sciences: The New Market-Share Leader

  26. A Checklist For Successful Medical Technology Investment

  27. Getting Started In Stocks

  28. Top 4 Most Scandalous Insider Trading Debacles

  29. 8 Stages Of New Drug Development

  30. Investing In Medical Equipment Companies

  31. Using DCF In Biotech Valuation

  32. Investing In The Biotech Sector

  33. 4 Reasons Why You Love To Hate Big Businesses

  34. Evaluating Pharmaceutical Companies

  35. A Primer On The Biotech Sector

  36. Government Regulations: Do They Help Businesses?

  37. 7 Popular Diet Plans And What They Cost

  38. Baby Boomers Beware: Financial Fraud That Targets Seniors

  39. Scandals That Bring The CEOs Out

  40. Infamous Female Financiers

  41. A Year In Product Recalls

  42. Pharma Patent Trolls: Cheap Drugs At A Steep Price

  43. Investing In The Healthcare Sector

  44. Chasing Down Biotech Zombie Stocks

  45. The Ups And Downs Of Biotechnology

Trading Center